Lista de obras - Bruno M. Costa - Dominio Público Uruguay

A multiplatform approach identifies miR-152-3p as a common epigenetically regulated onco-suppressor in prostate cancer targeting TMEM97.

artículo científico publicado en 2018

A novel molecular link between HOXA9 and WNT6 in glioblastoma identifies a subgroup of patients with particular poor prognosis

scientific article published on 10 January 2020

A semiautomated microfluidic platform for real-time investigation of nanoparticles' cellular uptake and cancer cells' tracking.

artículo científico publicado en 2017

Crosstalk between glial and glioblastoma cells triggers the "go-or-grow" phenotype of tumor cells.

artículo científico publicado en 2017

Disruption of the β1L Isoform of GABP Reverses Glioblastoma Replicative Immortality in a TERT Promoter Mutation-Dependent Manner

artículo científico publicado en 2018

Exploiting the Complexities of Glioblastoma Stem Cells: Insights for Cancer Initiation and Therapeutic Targeting

artículo científico publicado en 2020

Expression of histone methyltransferases as novel biomarkers for renal cell tumor diagnosis and prognostication

artículo científico publicado en 2015

Glioblastoma: Is There Any Blood Biomarker with True Clinical Relevance?

artículo científico publicado en 2020

HOX gene cluster (de)regulation in brain: from neurodevelopment to malignant glial tumours

scientific article published on 01 April 2020

Histone methyltransferase PRMT6 plays an oncogenic role of in prostate cancer

artículo científico publicado en 2016

Impact of mesenchymal stem cells' secretome on glioblastoma pathophysiology

artículo científico publicado en 2017

Influence of HOTAIR rs920778 and rs12826786 genetic variants on prostate cancer risk and progression-free survival.

artículo científico publicado en 2018

Loss of Caveolin-1 in Metastasis-Associated Macrophages Drives Lung Metastatic Growth through Increased Angiogenesis

artículo científico publicado en 2017

Mechanisms of initiation and reversal of drug-seeking behavior induced by prenatal exposure to glucocorticoids.

artículo científico publicado en 2011

Mesenchymal stem cells secretome as a modulator of the neurogenic niche: basic insights and therapeutic opportunities

artículo científico publicado en 2015

Molecular prognostic factors in glioblastoma: state of the art and future challenges

artículo científico publicado en 2013

Overexpression of circulating MiR-30b-5p identifies advanced breast cancer

artículo científico publicado en 2019

Phase II and pharmacogenomics study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme and gliosarcoma

artículo científico publicado en 2011

Plexin-A4 Mediates Cytotoxic T-cell Trafficking and Exclusion in Cancer

scientific article published on 23 November 2021

SETDB2 and RIOX2 are differentially expressed among renal cell tumor subtypes, associating with prognosis and metastization.

artículo científico publicado en 2017

Serum lactate levels are associated with glioma malignancy grade

scientific article published on 01 October 2019

Sirtuins' Deregulation in Bladder Cancer: SIRT7 Is Implicated in Tumor Progression through Epithelial to Mesenchymal Transition Promotion

artículo científico publicado en 2020

The cell secretome in personalized and regenerative medicine

scientific article published on 09 November 2018

The impact of Mesenchymal Stem Cells and their secretome as a treatment for gliomas

artículo científico publicado en 2018

The long non-coding RNA HOTAIR is transcriptionally activated by HOXA9 and is an independent prognostic marker in patients with malignant glioma.

artículo científico publicado en 2018

The tumoral A genotype of the MGMT rs34180180 single-nucleotide polymorphism in aggressive gliomas is associated with shorter patients' survival

artículo científico publicado en 2015

Transcriptional profiling of HOXA9-regulated genes in human glioblastoma cell models

artículo científico publicado en 2015

Understanding TERT Promoter Mutations: A Common Path to Immortality.

artículo científico publicado en 2016

Variant Rett syndrome in a girl with a pericentric X-chromosome inversion leading to epigenetic changes and overexpression of the MECP2 gene

artículo científico publicado en 2015

Lista de obras de Bruno M. Costa

A multiplatform approach identifies miR-152-3p as a common epigenetically regulated onco-suppressor in prostate cancer targeting TMEM97.

A novel molecular link between HOXA9 and WNT6 in glioblastoma identifies a subgroup of patients with particular poor prognosis

A semiautomated microfluidic platform for real-time investigation of nanoparticles' cellular uptake and cancer cells' tracking.

Crosstalk between glial and glioblastoma cells triggers the "go-or-grow" phenotype of tumor cells.

Disruption of the β1L Isoform of GABP Reverses Glioblastoma Replicative Immortality in a TERT Promoter Mutation-Dependent Manner

Exploiting the Complexities of Glioblastoma Stem Cells: Insights for Cancer Initiation and Therapeutic Targeting

Expression of histone methyltransferases as novel biomarkers for renal cell tumor diagnosis and prognostication

Glioblastoma: Is There Any Blood Biomarker with True Clinical Relevance?

HOX gene cluster (de)regulation in brain: from neurodevelopment to malignant glial tumours

Histone methyltransferase PRMT6 plays an oncogenic role of in prostate cancer

Impact of mesenchymal stem cells' secretome on glioblastoma pathophysiology

Influence of HOTAIR rs920778 and rs12826786 genetic variants on prostate cancer risk and progression-free survival.

Loss of Caveolin-1 in Metastasis-Associated Macrophages Drives Lung Metastatic Growth through Increased Angiogenesis

Mechanisms of initiation and reversal of drug-seeking behavior induced by prenatal exposure to glucocorticoids.

Mesenchymal stem cells secretome as a modulator of the neurogenic niche: basic insights and therapeutic opportunities

Molecular prognostic factors in glioblastoma: state of the art and future challenges

Overexpression of circulating MiR-30b-5p identifies advanced breast cancer

Phase II and pharmacogenomics study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme and gliosarcoma

Plexin-A4 Mediates Cytotoxic T-cell Trafficking and Exclusion in Cancer

SETDB2 and RIOX2 are differentially expressed among renal cell tumor subtypes, associating with prognosis and metastization.

Serum lactate levels are associated with glioma malignancy grade

Sirtuins' Deregulation in Bladder Cancer: SIRT7 Is Implicated in Tumor Progression through Epithelial to Mesenchymal Transition Promotion

The cell secretome in personalized and regenerative medicine

The impact of Mesenchymal Stem Cells and their secretome as a treatment for gliomas

The long non-coding RNA HOTAIR is transcriptionally activated by HOXA9 and is an independent prognostic marker in patients with malignant glioma.

The tumoral A genotype of the MGMT rs34180180 single-nucleotide polymorphism in aggressive gliomas is associated with shorter patients' survival

Transcriptional profiling of HOXA9-regulated genes in human glioblastoma cell models

Understanding TERT Promoter Mutations: A Common Path to Immortality.

Variant Rett syndrome in a girl with a pericentric X-chromosome inversion leading to epigenetic changes and overexpression of the MECP2 gene

is a novel oncogenic prognostic biomarker in human glioblastoma